Efficacy Study of GS010 for the Treatment of Vision Loss up to 6 Months From Onset in LHON Due to the ND4 Mutation
Condition(s):Optic, Atrophy, Hereditary, LeberLast Updated:July 29, 2022Completed
Hide Studies Not Open or Pending
Condition(s):Optic, Atrophy, Hereditary, LeberLast Updated:July 29, 2022Completed
Condition(s):ObesityLast Updated:October 8, 2021Completed
Condition(s):Clear Cell Renal Cell CarcinomaLast Updated:March 9, 2022Recruiting
Condition(s):Huntington’s DiseaseLast Updated:June 13, 2018Completed
Condition(s):Decompression SicknessLast Updated:April 28, 2023Recruiting
Condition(s):Carcinoma, Non-Small-Cell Lung; NeoplasmsLast Updated:June 1, 2022Completed
Condition(s):Epithelial Ovarian Cancer; Peritoneal Neoplasms; Fallopian Tube NeoplasmsLast Updated:May 30, 2017Terminated
Condition(s):Alzheimer Disease; Parkinson Disease; InflammationLast Updated:May 24, 2023Terminated
Condition(s):Atrial FibrillationLast Updated:May 9, 2023Recruiting
Condition(s):Friedreich AtaxiaLast Updated:December 6, 2022Active, not recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.